Owczarek Witold, Slowinska Monika, Walecka Irena, Ciazynska Magdalena, Nowicka Dorota, Walczak Leszek, Paluchowska Elwira
Department of Dermatology, Military Institute of Medicine, 01-755 Warsaw, Poland.
Clinic of Dermatology, Centre of Postgraduate Medical Education, Central Clinical Hospital of the Ministry of the Interior, 02-097 Warsaw, Poland.
Life (Basel). 2021 Feb 14;11(2):146. doi: 10.3390/life11020146.
Genital warts are the manifestation of the human papillomavirus (HPV) infection, which may last for weeks or months before the clinical presentation. The primary aim of the study was the correlation of the DNA HPV genotypes eradication with the treatment response in male patients with persistent genital warts.
Twenty-one male patients (age range: 22-58) after failure of cryotherapy and podophyllotoxin treatment were enrolled in the study. Genetic tests (Real Time - PCR method) analyzed the presence of DNA-HPV before and 6 months after four sessions (4 weeks apart) of photodynamic therapy with 5-aminolaevulinic acid (ALA-PDT). The treatment efficacy was evaluated before each PDT session and at the end of the study.
The single HPV DNA type was present in 15/21 of the patients (13/15 HPV6). The high-risk HPV types were found in 8/21 subjects, of which 6/8 had several types. Six months after four sessions of PDT, complete response was found in 16/21 (76.19%; = 0.0007) of patients, and DNA HPV clearance was found in 66.67% ( = 0.03). The eradication rate differed among patients with primary low-risk and high-risk HPV types-76.92% (10/13; = 0.0003) and 50% (4/8; = 0.05) respectively.
ALA-PDT is an effective treatment even after the failure of previous modalities. The persistence of clinical lesions and high oncological risk HPV types should be an indication for treatment prolongation.
尖锐湿疣是人乳头瘤病毒(HPV)感染的表现形式,在临床表现出现之前可能持续数周或数月。本研究的主要目的是探讨男性持续性尖锐湿疣患者中DNA HPV基因型清除与治疗反应之间的相关性。
21例(年龄范围:22 - 58岁)冷冻疗法和鬼臼毒素治疗失败后的男性患者纳入本研究。基因检测(实时荧光定量PCR法)分析了5-氨基酮戊酸光动力疗法(ALA-PDT)四个疗程(间隔4周)前后DNA-HPV的存在情况。在每次光动力治疗前及研究结束时评估治疗效果。
15/21的患者存在单一HPV DNA型(13/15为HPV6)。8/21的受试者检测到高危HPV型,其中6/8为多种类型。四个疗程的光动力治疗六个月后,16/21(76.19%;P = 0.0007)的患者获得完全缓解,66.67%(P = 0.03)的患者HPV DNA清除。原发性低危和高危HPV型患者的清除率有所不同,分别为76.92%(10/13;P = 0.0003)和50%(4/8;P = 0.05)。
即使先前治疗方式失败,ALA-PDT仍是一种有效的治疗方法。临床病变的持续存在和高危HPV型应作为延长治疗的指征。